Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
38.33%EBITDA Margin
VS
Market
Sector
Industry
History
$ 3.2Close
$ 0.43 - $ 3.45 52-Week Range
Ticker Information
Ticker
CTMXCompany Name
CYTOMX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCYTOMX THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CTMX - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 54.08M | 38.33% | $ 141.1M |
| 3/31/2025 | $ 47.7M | 32.33% | $ 147.56M |
| 12/31/2024 | $ 37.95M | 27.48% | $ 138.1M |
| 9/30/2024 | $ 20.89M | 16.5% | $ 126.62M |
| 6/30/2024 | $ 20.88M | 17.46% | $ 119.57M |
| 3/31/2024 | $ 26.34M | 22.1% | $ 119.18M |
| 12/31/2023 | $ 9.23M | 9.12% | $ 101.21M |
| 9/30/2023 | $ -20.59M | -27.26% | $ 75.55M |
| 6/30/2023 | $ -49.64M | -75.12% | $ 66.08M |
| 3/31/2023 | $ -72.82M | -122.33% | $ 59.52M |
Key Performance Insights, Last 5 Years
- CYTOMX THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at -70.94%.
- Over the past 5 years, CYTOMX THERAPEUTICS INC's average EBITDA % has been -55.01%.
- The median EBITDA % for CYTOMX THERAPEUTICS INC during this period was -73.03%
- CYTOMX THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at 38.33%.
- The lowest EBITDA % recorded by CYTOMX THERAPEUTICS INC in the same timeframe -175.8%
CYTOMX THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for CYTOMX THERAPEUTICS INC is calculated as follows: EBITDA [ $ -65.45M ] / Revenues [ $ 92.27M ]
(=) EBITDA % [ -70.94% ] CTMX - EBITDA Margin, Last 5 years
-175.8%
Minimum
Dec 31, 2022
38.33%
Maximum
Jun 30, 2025
-55.01%
Average
-73.03%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |